MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 6:137-139, (2006)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.6.3.4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willnow, T. E.
Right arrow Articles by Andersen, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willnow, T. E.
Right arrow Articles by Andersen, O. M.

Viewpoint

Pin-pointing APP Processing

Thomas E. Willnow and Olav M. Andersen

Max-Delbrueck-Center for Molecular Medicine, D-13125, Berlin, Germany

SUMMARY

The neuropathological hallmarks of Alzheimer Disease (AD) are neurofibrillar tangles composed of tau protein and neuritic plaques containing the amyloid ß-peptide (Aß) that is derived from proteolytic processing of the amyloid precursor protein (APP). Proline is the sole {alpha}-imino acid in nature's repertoire and, therefore, the only peptide residue that can exist in cis or trans conformation. When phosphorylated on serine or threonine found adjacent to proline, both tau and APP undergo conformational changes that promote the formation of tangles and, in the case of APP, processing to Aß. Now, new findings on the role of the Pin1, a peptidyl-prolyl cis/trans isomerase (PPIase) that catalyzes rotation of the protein backbone at proline residues, appear to indicate that Pin1 binds to and isomerizes distinct proline residues located in the commonly found phospho-Ser/Thr-Pro motif within APP to detangle APP fibers.Interestingly, the expression of Pin1 is decreased in degenerating neurons of AD patients and causes age-dependent neurodegeneration when deleted in mice.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.